ImmunityBio Inc. (NASDAQ:IBRX) is one of the 10 Must-Watch Stocks Right Now. ImmunityBio surged by 7.29 percent on Friday to ...

Methods developed and validated to establish the "World Bank of NK Cells" from healthy donors and cancer patients -- Single apheresis yields up to 5 billion (5×109) highly pure activated memory ...

Shares of ImmunityBio (IBRX) gained more than 3% in pre-market trading on Friday, after the pharmaceutical firm announced on Friday the completion of key manufacturing engineering programs supporting ...

Researchers in Brazil have engineered natural killer cells to better attack blood cancers, showing improved tumour control in ...

ImmunityBio Inc. IBRX shares are up on Friday morning as the company completed its manufacturing engineering programs for its NK cell therapy platform. • ImmunityBio shares are powering higher. Why is ...

ImmunityBio (IBRX) stock jumps as NK2022/NK2023 programs validate the company's Cytokine-Enriched NK Cell (m-ceNK) Platform. Read more here.

Researchers at the Ribeirao Preto Blood Center and the Center for Cell-Based Therapy (CTC) conducted a study using the NK-92 ...

A newly discovered genetic switch may allow scientists to dramatically amplify the cancer-killing power of natural immune cells by harnessing the body’s own signaling molecules. Credit: Shutterstock ...

Restoring the gut microbiota through fecal microbiota transplantation reversed these effects. The treatment replenished CX3CR1-positive NK cells, reduced lung damage, and improved survival. Targeted ...